Status: current, Primitive. Date: 31-Jul 2015. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3082412010 | Nintedanib (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3082413017 | Nintedanib | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Nintedanib | Is a | Piperazine derivative | true | Inferred relationship | Some | ||
| Nintedanib | Is a | Antineoplastic agent | true | Inferred relationship | Some | ||
| Nintedanib | Is a | Protein kinase inhibitor | true | Inferred relationship | Some | ||
| Nintedanib | Has disposition | Protein kinase inhibitor | true | Inferred relationship | Some | ||
| Nintedanib | Is a | Chemical categorised functionally | false | Inferred relationship | Some | ||
| Nintedanib | Is a | Enzyme inhibitor | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Nintedanib only product | Has active ingredient | True | Nintedanib | Inferred relationship | Some | 1 |
| Nintedanib only product in oral dose form | Has active ingredient | True | Nintedanib | Inferred relationship | Some | 1 |
| Nintedanib (as nintedanib esilate) 150 mg oral capsule | Has BoSS | True | Nintedanib | Inferred relationship | Some | 1 |
| Nintedanib esilate | Is modification of | True | Nintedanib | Inferred relationship | Some | |
| Nintedanib (as nintedanib esilate) 100 mg oral capsule | Has BoSS | True | Nintedanib | Inferred relationship | Some | 1 |
| Nintedanib-containing product | Has active ingredient | True | Nintedanib | Inferred relationship | Some | 1 |
| Nintedanib-containing product in oral dose form | Has active ingredient | True | Nintedanib | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR